# UK Single Photon Emission Computed Tomography Market > UK Single Photon Emission Computed Tomography Market Research Report: Size, Share, Trend Analysis By Types (Hybrid SPECT Systems, Standalone SPECT System), By Applications (Oncology, Cardiology, Neurology) and By End Users (Hospitals, Diagnostic Imaging Centers) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.59% - **2024:** $ 76.97 Million - **2025:** $ 82.04 Million - **2035:** $ 155.25 Million - **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Systems (JP), Nuclear Imaging (US) **Report ID:** MRFR/HC/48642-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-single-photon-emission-computed-tomography-market-50399 --- ## Market Summary ## **UK Single Photon Emission Computed Tomography Market Overview** As per MRFR analysis, the UK Single Photon Emission Computed Tomography Market Size was estimated at 71.98 (USD Million) in 2023. The UK Single Photon Emission Computed Tomography Market Industry is expected to grow from 77 (USD Million) in 2024 to 564 (USD Million) by 2035. The UK Single Photon Emission Computed Tomography Market CAGR (growth rate) is expected to be around 19.844% during the forecast period (2025 - 2035). ## **Key UK Single Photon Emission Computed Tomography Market Trends Highlighted** The UK Single Photon Emission Computed Tomography Market is impacted by some important trends and drivers. The growing incidence of chronic diseases like cancer and cardiovascular disorders is increasing the utilization of advanced imaging systems such as SPECT. The increased awareness regarding early diagnosis and its impact on the prognosis of the disease is further increasing the utilization of SPECT in the UK healthcare system. Furthermore, there is a continued movement towards the use of artificial intelligence and machine learning in imaging SPECT, which improves the reliability of diagnosis and enhances the workflow. The progress that is being made in radiopharmaceuticals and the invention of hybrid imaging techniques are also influencing the market by providing enhanced characterization of the disease and treatment planning. Government initiatives and healthcare funding are still proving favorable for the development of the SPECT market in the UK. The National Health Service (NHS) is spending more and more on advanced diagnostic equipment and technologies, which increase the opportunity for SPECT applications. Also, increasing multidisciplinary research and collaboration between academic institutions and industries is bound to lead to novel innovations in imaging techniques that can enhance patient care. There is also a recent trend on precision medicine which creates demand for more specific and focused treatment methods that further highlights SPECT’s value in cancer and heart disease detection and diagnosis. These developments make SPECT a major information source for UK clinicians as the UK shifts towards value-based healthcare. The market is also responding to the new trend of cost-efficient measures, where hospitals aim to achieve more outcomes for the least possible budget which makes adopting SPECT technology essential to aid shifting approaches in UK healthcare. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **UK Single Photon Emission Computed Tomography Market Drivers** ### **Increasing Prevalence of Cancer and Cardiovascular Diseases** The UK has witnessed a significant rise in the number of cancer and cardiovascular disease cases, driving the demand for advanced diagnostic imaging technologies such as Single Photon Emission Computed Tomography (SPECT). According to Public Health England, cancer diagnoses in the UK increased by more than 6% from 2015 to 2020, contributing to around 367,000 new cancer cases each year. This surge necessitates enhanced imaging methods to aid in detection and treatment planning. With the NHS focusing on improving cancer services and investing in advanced diagnostic tools, the UK Single Photon Emission Computed Tomography Market Industry is positioned for substantial growth. Established healthcare organizations like the National Health Service and Cancer Research UK emphasize the importance of effective diagnostic imaging, which supports the adoption of SPECT technology in clinical settings. These market dynamics indicate a continued demand for high-quality imaging solutions to address the growing healthcare requirements. ### **Technological Advancements in Imaging Technology** Recent advancements in imaging technology have revolutionized the landscape of medical diagnostics. Innovations in Single Photon Emission Computed Tomography (SPECT) instruments, including improved image resolution and detection capabilities, have enhanced diagnostic accuracy. The UK is seeing increased investments by established companies like Siemens Healthineers and GE Healthcare in developing cutting-edge SPECT systems that offer advanced features like hybrid imaging and optimized workflows. According to the Department of Health and Social Care, nearly 40% of all medical imaging is now digital, which indicates a growing trend toward adopting advanced diagnostic tools that include SPECT. These improvements not only enhance patient outcomes but also drive the growth of the UK Single Photon Emission Computed Tomography Market Industry, reflecting the importance of staying abreast of technological advancements. ### **Government Initiatives and Funding in Healthcare** The UK government has been active in promoting health initiatives that focus on improving diagnostic capabilities in the healthcare sector. The National Health Service Long Term Plan aims to expand cancer services and improve diagnostic pathways by increasing access to advanced imaging technologies like Single Photon Emission Computed Tomography (SPECT). Recent budget allocations have earmarked substantial funds for improving cancer diagnostics and treatment services, making SPECT a significant component of this strategy. As stated in government reports, funding for equipment upgrades and new technology is prioritized to meet the growing patient demands. This supportive funding climate positively influences the UK Single Photon Emission Computation Tomography Market Industry, fostering an environment conducive to growth and innovation. ## **UK Single Photon Emission Computed Tomography Market Segment Insights** ### **Single Photon Emission Computed Tomography Market Type Insights** The UK Single Photon Emission Computed Tomography Market is shaping up to be a significant component of the healthcare industry, particularly in diagnostic imaging. This market segment can primarily be divided into Hybrid SPECT Systems and Standalone SPECT Systems, each having its own distinct role in advancing medical diagnostics. Hybrid SPECT Systems integrate functionalities with modalities like Computed Tomography (CT) or Magnetic Resonance Imaging (MRI), providing enhanced image quality and comprehensive anatomical and functional information in a single scan. This combination is crucial for accurate disease detection and monitoring, especially in complex cases like oncology and cardiology. The growing demand for precise diagnostic tools and the increasing prevalence of chronic diseases in the UK contribute to the favorable outlook for Hybrid SPECT Systems. On the other hand, Standalone SPECT Systems also play a vital role in the landscape of nuclear medicine. These systems are characterized by their simplicity and focused application in specific diagnostic tasks, such as the evaluation of brain and cardiac conditions. They offer a cost-effective solution, especially for smaller medical facilities that require essential imaging capabilities without the complexities of hybrid systems. The clarity of images generated by standalone systems enables healthcare providers in the UK to make informed clinical decisions quickly. The ongoing innovations and technological advancements in both segments are being driven by the need for higher efficiency and accuracy in medical imaging. Developments such as improved detectors and algorithms are enhancing image resolution and reducing patient radiation exposure, making SPECT a more attractive option for health professionals. Furthermore, as the UK government continues to invest in healthcare infrastructure and research initiatives, there is an increasing opportunity for the growth of both Hybrid and Standalone SPECT Systems, reflecting the demand for improved diagnostic services across the nation. This trend showcases the importance and interdependence of both types of systems in the broader context of radiology and patient care, paving the way for a more effective healthcare delivery system in the UK. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Single Photon Emission Computed Tomography Market Application Insights** The UK [Single Photon Emission Computed Tomography Market](../../../reports/single-photon-emission-computed-tomography-market-7231) is witnessing notable growth within the Application segment, primarily driven by the increasing demand for advanced imaging techniques in the healthcare sector. In particular, the oncology sector plays a crucial role, as Single Photon Emission Computed Tomography is increasingly utilized for cancer detection, treatment monitoring, and follow-up care. This imaging modality enables precise localization of tumors and assessment of metabolic activity, significantly enhancing diagnostic accuracy. Furthermore, cardiology applications are increasingly gaining traction due to the rising prevalence of cardiovascular diseases. The ability of Single Photon Emission Computed Tomography to provide valuable insights into cardiac function and blood flow is vital in managing conditions such as coronary artery disease. Neurology is another important area, as this technology aids in the diagnosis of neurological disorders, including dementia and epilepsy, allowing clinicians to monitor brain function and assess the effectiveness of treatments. These trends underscore the critical role of the Application segment in advancing patient care and the overall functionality of the UK healthcare system. With ongoing developments in imaging technology and a growing patient population requiring detailed analysis, the significance of these applications is likely to expand further in the coming years. ### **Single Photon Emission Computed Tomography Market End User Insights** The End User segment of the UK Single Photon Emission Computed Tomography Market plays a critical role in the overall landscape, primarily comprising Hospitals and Diagnostic Imaging Centers. Hospitals are significant contributors, as they integrate advanced imaging technologies into their services, enhancing diagnostics for various health conditions. The growing emphasis on early disease detection and personalized treatment plans drives the demand for single photon emission computed tomography in these facilities. Diagnostic Imaging Centers complement this trend by offering specialized services that cater to patients requiring advanced imaging solutions outside hospital settings. These centers often provide rapid access to scans, which is essential for timely diagnoses. The increasing prevalence of chronic diseases and the aging population in the UK further bolster the need for these imaging modalities, presenting opportunities for growth within this market segment. Moreover, advancements in technology, healthcare policies promoting diagnostic imaging, and rising patient awareness contribute to a positive outlook for both Hospitals and Diagnostic Imaging Centers within the UK Single Photon Emission Computed Tomography Market. As these end users expand their capabilities, they enhance the overall efficiency and quality of patient care, thus reflecting the dynamic nature of this vital market segment. ## **UK Single Photon Emission Computed Tomography Market Key Players and Competitive Insights** The UK Single Photon Emission Computed Tomography Market exhibits a dynamic framework characterized by rapid technological advancements and significant player engagement. With increasing demand for precise diagnostic imaging solutions, competition in this sector has intensified, driven by innovations in imaging technology, efficiency, and cost-effectiveness. Companies operating within this landscape are striving to differentiate their product offerings and improve their market share, often focusing on developing more compact, user-friendly machines with enhanced image quality and reduced radiation exposure. The market's competitive environment is marked by collaborations, partnerships, and strategic alliances aimed at leveraging complementary strengths and capabilities to meet the evolving needs of healthcare providers and patients alike. Mediso Medical Imaging Systems stands out as a key competitor in the UK Single Photon Emission Computed Tomography Market due to its specialized focus on hybrid imaging technologies that combine multiple imaging modalities for optimized diagnostic capabilities. The company's commitment to high-quality imaging solutions enhances its reputation among healthcare professionals in the UK. Mediso’s robust technical prowess and established presence allow it to offer products with advanced functionalities, appealing to healthcare institutions seeking innovative imaging technologies. The company’s proactive approach to customer service and support reinforces its strength in the market, enabling healthcare providers to fully utilize its imaging systems for improved patient outcomes while fostering a loyal customer base. Samsung Medison is another significant player in the UK Single Photon Emission Computed Tomography Market, recognized for its commitment to integrating cutting-edge technology into its medical imaging systems. The company emphasizes a range of key products, including advanced imaging software and state-of-the-art SPECT systems that cater to the diagnostic imaging needs of the UK healthcare sector. Samsung Medison’s strengths lie in its continuous innovation and investment in research and development, which has led to groundbreaking products designed for optimal performance and accuracy. Moreover, the company has implemented strategic partnerships and collaborations to expand its market presence and enhance its service offerings. This focus on growth is complemented by mergers and acquisitions aimed at consolidating its position in the market and broadening its product portfolio, further establishing Samsung Medison as a formidable competitor within the UK Single Photon Emission Computed Tomography landscape. ## **Key Companies in the UK Single Photon Emission Computed Tomography Market Include** - Mediso Medical Imaging Systems - Samsung Medison - Esaote - **[Carestream Health](https://www.carestream.com/blog/2019/07/15/dual-modality-imaging-systems-enhance-productivity-and-workflow/)** - Trilogy MedTech - Philips Healthcare - Shenzhen Anke Hightech Co - CTI Molecular Imaging - Digirad Corporation - General Electric - Nuclear Imaging Technologies - Siemens Healthineers - Canon Medical Systems - Toshiba Medical Systems - NeuroLogica ## **UK Single Photon Emission Computed Tomography Market Industry Developments** Recent developments in the UK Single Photon Emission Computed Tomography (SPECT) Market highlight significant advancements and strategic shifts among key players. Companies such as Philips Healthcare and Siemens Healthineers have seen growing demand for their diagnostic imaging solutions, particularly as healthcare providers seek to enhance patient care and efficiency. In September 2023, Mediso Medical Imaging Systems expanded its product line, aiming to integrate more advanced imaging technologies, which has encouraged other manufacturers to follow suit. Additionally, in light of emerging technologies, April 2023 saw General Electric and Canon Medical Systems announcing collaborative efforts to innovate imaging techniques, focusing on enhancing SPECT capabilities. On the mergers and acquisitions front, in June 2023, Esaote completed the acquisition of a niche imaging firm specializing in software solutions, which is expected to bolster its market position significantly. Growth in the market valuation for companies like Samsung Medison and Digirad Corporation indicates a robust competitive landscape, driven by advancements in imaging technology and increased healthcare spending. Recent investments and product innovations reflect a collective commitment to improving diagnostic accuracy and patient outcomes within the UK healthcare system. ## **UK Single Photon Emission Computed Tomography Market Segmentation Insights** ### **Single Photon Emission Computed Tomography Market Type Outlook**  - Hybrid SPECT Systems - Standalone SPECT System ### **Single Photon Emission Computed Tomography Market Application Outlook** - Oncology - Cardiology - Neurology ### **Single Photon Emission Computed Tomography Market End User Outlook** - Hospitals - Diagnostic Imaging Centers ## Market Drivers ### Growing Geriatric Population The demographic shift towards an aging population in the UK is a crucial driver for the single photon-emission-computed-tomography market. As individuals age, the likelihood of developing various health conditions increases, necessitating regular [diagnostic imaging](https://www.marketresearchfuture.com/reports/diagnostic-imaging-market-6765). The Office for National Statistics indicates that the proportion of people aged 65 and over is projected to rise significantly, leading to a higher demand for effective diagnostic tools. Single photon-emission-computed-tomography is particularly valuable in assessing age-related diseases, such as dementia and cardiovascular disorders. Consequently, the increasing geriatric population is likely to stimulate the growth of the single photon-emission-computed-tomography market, as healthcare providers seek to meet the diagnostic needs of this demographic. ### Increased Healthcare Expenditure The rise in healthcare expenditure in the UK is a notable driver for the single photon-emission-computed-tomography market. With the government and private sectors investing more in healthcare infrastructure, there is a growing emphasis on advanced diagnostic technologies. The UK government has committed to increasing the NHS budget, which is expected to enhance the availability of sophisticated imaging modalities. This financial support may lead to the procurement of more single photon-emission-computed-tomography systems in hospitals and diagnostic centers. As healthcare facilities upgrade their equipment to meet modern standards, the demand for SPECT technology is likely to increase, thereby fostering growth in the single photon-emission-computed-tomography market. ### Rising Awareness of Early Diagnosis The growing awareness of the importance of early diagnosis among patients and healthcare providers is a significant driver for the single photon-emission-computed-tomography market. Educational campaigns and initiatives aimed at promoting preventive healthcare are encouraging individuals to seek diagnostic imaging services sooner. This shift in mindset is particularly relevant in the context of diseases that benefit from early detection, such as cancer and heart disease. As patients become more proactive about their health, the demand for effective imaging solutions like single photon-emission-computed-tomography is likely to rise. This trend suggests a potential increase in market growth as healthcare providers adapt to meet the evolving expectations of patients regarding timely and accurate diagnoses. ### Technological Innovations in Imaging Technological advancements in imaging modalities are significantly influencing the single photon-emission-computed-tomography market. Innovations such as improved detector technologies and advanced reconstruction algorithms enhance image quality and reduce scan times, making SPECT more efficient and user-friendly. The integration of artificial intelligence in image analysis further streamlines diagnostic processes, potentially increasing the adoption of SPECT in clinical settings. As healthcare facilities in the UK strive to provide high-quality patient care, the demand for cutting-edge imaging technologies is expected to grow. The market for single photon-emission-computed-tomography is projected to expand as these innovations become more prevalent, enabling healthcare providers to offer more accurate and timely diagnoses. ### Rising Prevalence of Chronic Diseases The increasing incidence of chronic diseases in the UK is a pivotal driver for the single photon-emission-computed-tomography market. Conditions such as cardiovascular diseases and cancer necessitate advanced diagnostic imaging techniques for effective management and treatment. According to recent health statistics, chronic diseases account for approximately 70% of all deaths in the UK, highlighting the urgent need for reliable diagnostic tools. Single photon-emission-computed-tomography offers enhanced imaging capabilities, allowing for early detection and monitoring of these conditions. As healthcare providers seek to improve patient outcomes, the demand for sophisticated imaging modalities is likely to rise, thereby propelling the growth of the single photon-emission-computed-tomography market. This trend underscores the importance of investing in advanced imaging technologies to address the healthcare challenges posed by chronic diseases. ## Future Outlook The single photon-emission-computed-tomography market is projected to grow at a 6.59% CAGR from 2025 to 2035, driven by technological advancements and increasing diagnostic applications. **New opportunities:** - Development of AI-driven imaging analysis software for enhanced diagnostic accuracy. - Expansion of mobile SPECT units for remote healthcare services. - Partnerships with pharmaceutical companies for radiopharmaceutical development. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Type: Hybrid SPECT Systems (Largest) vs. Standalone SPECT System (Fastest-Growing) In the UK single photon-emission-computed-tomography market, Hybrid SPECT Systems hold the largest market share, driven by their advanced imaging capabilities and integration with other imaging modalities. These systems enable enhanced diagnostics and improved patient outcomes, making them the preferred choice among healthcare facilities. Conversely, Standalone SPECT Systems, while smaller in market share, are experiencing rapid growth due to their cost-effectiveness and simplicity, which cater to specific clinical needs. Hybrid SPECT Systems (Dominant) vs. Standalone SPECT System (Emerging) Hybrid SPECT Systems are recognized as the dominant force in the market, combining SPECT imaging with modalities like CT or MRI, which provide comprehensive diagnostic information. They are highly valued for their precision and ability to perform multi-functional tasks, leading to increased adoption among medical practitioners. On the other hand, Standalone SPECT Systems are emerging as a viable alternative, particularly in smaller healthcare settings, where budget constraints require efficient solutions without compromising quality. Their simplicity and lower operational costs facilitate their integration into various imaging protocols, thus expanding their appeal and market share. ### By Application: Oncology (Largest) vs. Cardiology (Fastest-Growing) In the UK single photon-emission-computed-tomography market, the distribution of market share among various application segments illustrates a clear preference for oncology, which dominates with a significant share. Meanwhile, cardiology is emerging as a robust segment, gaining traction as healthcare providers increasingly recognize the value of advanced diagnostic techniques. Neurology, while important, has a smaller market share compared to the other two segments, reflecting more specialized applications. Growth trends in the application segments are indicative of broader healthcare advancements. Oncology continues to lead, driven by rising cancer incidences and increased investments in diagnostic technologies. Cardiology, on the other hand, is the fastest-growing segment as cardiovascular diseases rise, prompting demand for early detection methods. Advances in technology and supportive regulatory frameworks are crucial drivers enhancing the appeal of these segments. Oncology (Dominant) vs. Cardiology (Emerging) Oncology stands out as the dominant application segment within the UK single photon-emission-computed-tomography market, primarily due to the growing burden of cancer and ongoing improvements in imaging techniques that allow for better diagnosis and treatment planning. The segment benefits from extensive research and a strong emphasis on early detection, positioning itself as a critical component of cancer care. In contrast, cardiology is recognized as the emerging segment, reflecting a paradigm shift towards proactive cardiovascular care. It leverages advancements in imaging technology, thus enhancing diagnostic capabilities for a range of heart conditions. The escalating prevalence of cardiovascular diseases combined with increased public awareness fosters its growth, establishing a strong competitive landscape against oncology. ### By End-User: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing) In the UK single photon-emission-computed-tomography market, hospitals constitute the largest segment, dominating the market share significantly. This large footprint can be attributed to the extensive infrastructure and funding that hospitals generally possess, enabling them to invest in advanced imaging technologies. On the other hand, diagnostic imaging centers are emerging as the fastest-growing segment, driven by the increasing demand for specialized imaging services and quicker medical diagnostics. Factors such as the rise in aging populations and the availability of technologically advanced imaging solutions contribute to this growth, making imaging centers a vital part of the healthcare ecosystem. Hospitals (Dominant) vs. Diagnostic Imaging Centers (Emerging) Hospitals are the dominant players in the UK single photon-emission-computed-tomography market, praised for their comprehensive healthcare services and the ability to offer a wide range of diagnostic tests under one roof. They often have state-of-the-art imaging systems and are well-funded, which allows them to stay updated with the latest advancements in nuclear medicine. Conversely, diagnostic imaging centers represent an emerging segment that is quickly gaining traction due to advancements in imaging technology and the increasing focus on outpatient services. These centers are becoming crucial for addressing patient needs efficiently and provide specialized and cost-effective solutions for imaging, thereby complementing hospital services in the overall healthcare landscape. ## Competitive Benchmarking The single photon-emission-computed-tomography market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for precise diagnostic imaging. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, each adopting distinct strategies to enhance their market presence. GE Healthcare (US) focuses on innovation through the development of advanced imaging technologies, while Siemens Healthineers (DE) emphasizes partnerships and collaborations to expand its product offerings. Philips Healthcare (NL) is actively pursuing digital transformation initiatives, integrating AI and data analytics into its imaging solutions, thereby shaping a competitive environment that prioritizes technological superiority and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market appears moderately fragmented, with a mix of established players and emerging companies vying for market share. The collective influence of these key players fosters a competitive structure that encourages innovation and responsiveness to market demands, ultimately benefiting healthcare providers and patients alike. In October Siemens Healthineers (DE) announced a strategic partnership with a leading AI firm to enhance its imaging capabilities. This collaboration aims to integrate AI algorithms into their SPECT systems, potentially improving diagnostic accuracy and workflow efficiency. Such a move underscores Siemens' commitment to leveraging cutting-edge technology to maintain its competitive edge in the market. In September GE Healthcare (US) launched a new line of SPECT imaging systems designed to reduce radiation exposure while maintaining high image quality. This initiative not only aligns with growing regulatory pressures for safer imaging practices but also positions GE as a leader in patient safety and technological innovation. The introduction of these systems is likely to attract healthcare facilities seeking to enhance their imaging capabilities without compromising patient care. In August Philips Healthcare (NL) unveiled a comprehensive digital platform that integrates SPECT imaging with cloud-based analytics. This platform aims to streamline workflows and provide real-time insights for clinicians, thereby enhancing decision-making processes. The strategic importance of this development lies in its potential to transform how healthcare providers utilize imaging data, fostering a more integrated approach to patient care. As of November the competitive trends in the single photon-emission-computed-tomography market are increasingly defined by digitalization, sustainability, and AI integration. Strategic alliances are becoming pivotal, as companies recognize the need to collaborate to stay ahead in a rapidly evolving landscape. Looking forward, competitive differentiation is likely to shift from price-based competition to a focus on innovation, advanced technology, and supply chain reliability, reflecting the industry's response to the growing demand for high-quality, efficient healthcare solutions. ## Recent News & Developments Recent developments in the UK [Single Photon Emission Computed Tomography](https://www.marketresearchfuture.com/reports/single-photon-emission-computed-tomography-market-7231) Market (SPECT) Market highlight significant advancements and strategic shifts among key players. Companies such as Philips Healthcare and Siemens Healthineers have seen growing demand for their diagnostic imaging solutions, particularly as healthcare providers seek to enhance patient care and efficiency. In September 2023, Mediso Medical Imaging Systems expanded its product line, aiming to integrate more advanced imaging technologies, which has encouraged other manufacturers to follow suit. Additionally, in light of emerging technologies, April 2023 saw General Electric and Canon Medical Systems announcing collaborative efforts to innovate imaging techniques, focusing on enhancing SPECT capabilities. On the mergers and acquisitions front, in June 2023, Esaote completed the acquisition of a niche imaging firm specializing in software solutions, which is expected to bolster its market position significantly. Growth in the market valuation for companies like Samsung Medison and Digirad Corporation indicates a robust competitive landscape, driven by advancements in imaging technology and increased healthcare spending. Recent investments and product innovations reflect a collective commitment to improving diagnostic accuracy and patient outcomes within the UK healthcare system. ## Report Scope | MARKET SIZE 2024 | 76.97(USD Million) | | --- | --- | | MARKET SIZE 2025 | 82.04(USD Million) | | MARKET SIZE 2035 | 155.25(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.59% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Systems (JP), Nuclear Imaging (US) | | Segments Covered | Type, Application, End-User | | Key Market Opportunities | Advancements in imaging technology enhance diagnostic accuracy in the single photon-emission-computed-tomography market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the single photon-emission-computed-tomography market. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What was the market valuation of the UK single photon-emission-computed-tomography market in 2024?** A: The market valuation was $76.97 Million in 2024. **Q: What is the projected market valuation for the UK single photon-emission-computed-tomography market by 2035?** A: The projected valuation for 2035 is $155.25 Million. **Q: What is the expected CAGR for the UK single photon-emission-computed-tomography market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 6.59%. **Q: Which companies are considered key players in the UK single photon-emission-computed-tomography market?** A: Key players include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Elekta, Medtronic, Hitachi Medical Systems, and Nuclear Imaging. **Q: What are the main types of systems in the UK single photon-emission-computed-tomography market?** A: The main types are Hybrid SPECT Systems and Standalone SPECT Systems. **Q: What were the market values for Hybrid SPECT Systems and Standalone SPECT Systems in 2024?** A: In 2024, Hybrid SPECT Systems were valued at $40.0 Million, while Standalone SPECT Systems were valued at $36.97 Million. **Q: What applications dominate the UK single photon-emission-computed-tomography market?** A: The dominant applications are Oncology, Cardiology, and Neurology. **Q: What were the market values for Oncology, Cardiology, and Neurology applications in 2024?** A: In 2024, Oncology was valued at $20.0 Million, Cardiology at $30.0 Million, and Neurology at $26.97 Million. **Q: Who are the primary end-users of single photon-emission-computed-tomography systems in the UK?** A: Primary end-users include Hospitals and Diagnostic Imaging Centers. **Q: What were the market values for Hospitals and Diagnostic Imaging Centers in 2024?** A: In 2024, Hospitals were valued at $40.0 Million, while Diagnostic Imaging Centers were valued at $36.97 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-single-photon-emission-computed-tomography-market-50399*